.svg){kind=small}
Mar-2026
Sales
Trend
6-Month
Product Count
SKUs
Overview
Market Insights Snapshot
Chronic Health has demonstrated notable performance in the Arizona market, particularly in the Tincture & Sublingual category. The brand maintained a strong presence, starting with a third-place rank in December 2025, holding steady in January 2026, and slightly dropping to fourth in February before climbing to second in March. This upward movement in March, coupled with an increase in sales from February to March, indicates a positive trend and suggests effective strategies in place to boost their market position. Conversely, the fluctuation in rankings earlier in the year could highlight competitive pressures or shifts in consumer preferences within the category.
In the Topical category within Arizona, Chronic Health also showed resilience and adaptability. Starting from a solid second place in December 2025, the brand faced a dip to third in January and further to fifth in February. However, by March, Chronic Health had regained its position as the second-ranked brand. This rebound, accompanied by a steady increase in sales from January through March, reflects a recovery and possibly an effective response to competitive challenges. The brief fall out of the top three in February could have been a critical point, but the subsequent recovery suggests that the brand's strategies are effectively aligning with consumer demands and market dynamics.
Competitive Landscape
In the Arizona Topical category, Chronic Health has demonstrated a resilient performance amidst a competitive landscape. Over the months from December 2025 to March 2026, Chronic Health's rank fluctuated but remained consistently within the top 5, moving from 2nd place in December 2025 to 3rd in January 2026, dropping to 5th in February, and then climbing back to 2nd in March. This indicates a strong recovery and adaptability in the market. Notably, Drip Oils + Extracts maintained its lead, consistently holding the 1st position throughout these months, which suggests a significant competitive pressure on Chronic Health. Meanwhile, Müv / MUV and Tru Infusion also posed competition, with Müv / MUV ranking 2nd in January and 4th in March, and Tru Infusion showing a notable improvement by securing the 3rd spot in March. Despite these challenges, Chronic Health's sales trajectory shows a positive trend, particularly with a notable increase in March, suggesting effective strategies in capturing market share and consumer interest.
Notable Products
In March 2026, the top-performing product for Chronic Health was the Indica THC Glycerin Tincture (100mg THC, 1oz) in the Tincture & Sublingual category, maintaining its number one rank since December 2025 with sales of $607. The CBD/THC 1:1 Pain Relief Ointment (175mg CBD, 175mg THC, 2oz) held steady at the second position, showing a significant increase in sales from February 2026. The CBD/THC 1:1 Sleep Well Tincture (100mg CBD, 100mg THC, 1oz) remained in third place, with a notable rise in sales figures compared to the previous month. The CBD/THC 1:1 Glycerin Tincture (100mg CBD, 100mg THC, 1oz) consistently ranked fourth over the past four months. A new entrant, THC Pain Relief Lotion (100mg), debuted in fifth place, indicating strong initial sales.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
